Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
Summary
- Eligibility
- for people ages 1 month to 30 years (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Julia Chu, MD
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Julia Chu, MD
Assistant Professor, Pediatrics, School of Medicine
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- New York Medical College
- ID
- NCT04197596
- Phase
- Phase 1/2 Research Study
- Study Type
- Interventional
- Participants
- Expecting 40 study participants
- Last Updated